Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Weiser

Showing results (231-240 of 292) with videos related to

Pageof 30
Sort By:
Oncoimmunology|November 25, 2020
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancerRosa M Jimenez-Rodriguez, Sujata Patil, Ajaratu Keshinro, et al.
JCO Oncology Advances|February 25, 2026
Risk of Residual Cancer following Immediate Surgery or Nonoperative Management after Malignant Colorectal Polypectomy with High-Risk FeaturesThikhamporn Tawantanakorn, A Begum Bektas, Matthew Hill, et al.
JAMA Network Open|September 29, 2022
A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait ManagementMartin R Weiser, Joanne F Chou, Jin K Kim, et al.
JAMA Network Open|November 8, 2021
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and SurgeryMartin R Weiser, Joanne F Chou, Ajaratu Keshinro, et al.
The American Journal of Surgical Pathology|March 25, 2008
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?Jinru Shia, Laura H Tang, Martin R Weiser, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
British Journal of Anaesthesia|June 19, 2022
Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort studyJonathan B Yuval, Jasme Lee, Fan Wu, et al.
Melanoma Research|October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanomaAlexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Annals of Surgical Oncology|March 25, 2023
MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall SurvivalHannah M Thompson, David D B Bates, Jennifer Golia Pernicka, et al.
Journal of the National Cancer Institute|June 27, 2024
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapySean J Judge, Parisa Malekzadeh, Marina J Corines, et al.
Pageof 30

Showing results (231-240 of 292) with videos related to

Sort By:
Pageof 30
Oncoimmunology|November 25, 2020
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancerRosa M Jimenez-Rodriguez, Sujata Patil, Ajaratu Keshinro, et al.
JCO Oncology Advances|February 25, 2026
Risk of Residual Cancer following Immediate Surgery or Nonoperative Management after Malignant Colorectal Polypectomy with High-Risk FeaturesThikhamporn Tawantanakorn, A Begum Bektas, Matthew Hill, et al.
JAMA Network Open|September 29, 2022
A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait ManagementMartin R Weiser, Joanne F Chou, Jin K Kim, et al.
JAMA Network Open|November 8, 2021
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and SurgeryMartin R Weiser, Joanne F Chou, Ajaratu Keshinro, et al.
The American Journal of Surgical Pathology|March 25, 2008
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?Jinru Shia, Laura H Tang, Martin R Weiser, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
British Journal of Anaesthesia|June 19, 2022
Intraoperative opioids are associated with decreased recurrence rates in colon adenocarcinoma: a retrospective observational cohort studyJonathan B Yuval, Jasme Lee, Fan Wu, et al.
Melanoma Research|October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanomaAlexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Annals of Surgical Oncology|March 25, 2023
MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall SurvivalHannah M Thompson, David D B Bates, Jennifer Golia Pernicka, et al.
Journal of the National Cancer Institute|June 27, 2024
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapySean J Judge, Parisa Malekzadeh, Marina J Corines, et al.
Pageof 30